An update from Dr. Mitchell Cairo on his research and treatments, emailed to David on December 16, 2017: The Marisa Fund has been responsible for supporting a new clinical research trial in the adolescents and young adults with Hodgkin Lymphoma. The primary aim is to investigate the use of targeted therapy using antibodies and antibody-conjugates … Continue reading Update from Dr. Mitchell Cairo